Other metastases genes associated with poor prognosis in breast cancer, such as CEACAM6, COL17A1, CXCL8, TNFAIP3, SEMA7A and L1CAM [31,38,39,40,41], are also attenuated with SP receptor antagonist treatment. This evidence concerns the gene SEMA7A and breast carcinoma.